Strategies for recombinant allergen vaccines and fruitful results from first clinical studies

Oliver Cromwell1, Helmut Fiebig, Roland Suck

  • 1Research and Development, Allergopharma Joachim Ganzer KG, Hermann-Koerner-Strasse 52, D-21465 Reinbek, Germany. oliver.cromwell@allergopharma.de